Synlett 2005(12): 1809-1827  
DOI: 10.1055/s-2005-871575
ACCOUNT
© Georg Thieme Verlag Stuttgart · New York

A Review of Advances in the Synthesis of Analogues of the Delphinium ­Alkaloid Methyllycaconitine

Kirsten J. Goodall, David Barker, Margaret A. Brimble*
Department of Chemistry, University of Auckland, 23 Symonds St., Auckland 1020, New Zealand
Fax: +64(9)3737422; e-Mail: m.brimble@auckland.ac.nz;
Weitere Informationen

Publikationsverlauf

Received 22 February 2005
Publikationsdatum:
22. Juni 2005 (online)

Abstract

Neuronal nicotinic acetylcholine receptors of the α7 sub-type are potential targets for drug development in the treatment of Alzheimer’s disease. The Delphinium alkaloid methyllycaconitine is a potent and selective α7 sub-type selective nicotinic acetylcholine receptor antagonist. The total synthesis of this pharmacologically active alkaloid has not yet been achieved. A summary of semi-synthetic methods to prepare methyllycaconitine is presented. ­Existing synthetic strategies used to prepare E, AE, AEF, ABE, ­ABDE, ABEF ring analogues of methyllycaconitine are reviewed for the first time.

  • 1 Introduction

  • 1.1 Alzheimer’s Disease and α7 Nicotinic Acetylcholine ­Receptors

  • 1.2 Methyllycaconitine - An α7 Subtype Selective Nicotinic Acetylcholine Receptor Antagonist

  • 1.3 Structure-Activity Relationships of Delphinium Alkaloids

  • 2 Semi-Syntheses of Delphinium Alkaloids

  • 3 Synthesis of Analogues of Methyllycaconitine

  • 3.1 Synthesis of E Ring Analogues of Methyllycaconitine

  • 3.2 Synthesis of AE Ring Bicyclic Analogues of Methyl­lycaconitine

  • 3.3 Synthesis of AEF Ring Tricyclic Analogues of Methyl­lycaconitine

  • 3.4 Synthesis of ABE Ring Tricyclic Analogues of Methyl­lycaconitine

  • 3.5 Synthesis of ABDE Ring Tetracyclic Analogues of Methyllycaconitine

  • 3.6 Synthesis of ABEF Ring Tetracyclic Analogues of Methyllycaconitine

  • 4 Conclusion

    References

  • 1 Cooper JR. Bloom FE. Roth RH. The Biochemical Basis of Neuropharmacology   8th ed.:  Oxford University Press; Oxford: 2003. 
  • 2 Levin ED. Rezvani AH. Eur. J. Pharmacol.  2000,  393:  141 
  • 3 Hellstrom-Lindahl E. Eur. J. Pharmacol.  2000,  393:  255 
  • 4 Marx J. Science  1996,  273:  50 
  • 5 Papke RL. Meyer E. Nutter T. Uteshev VV. Eur. J. Pharmacol.  2000,  393:  179 
  • 6 Pereira EFR. Hilmas C. Santos MD. Alkondon M. Maelicke A. Albuquerque EX. J. Neurobiol.  2002,  53:  479 
  • 7 Levin ED. Bradley A. Addy N. Sigurani N. Neuroscience  2002,  109:  757 
  • 8 Clementi F. Fornasari D. Gotti C. Eur. J. Pharmacol.  2000,  393:  3 
  • 9 Holladay MW. Dart MJ. Lynch JK. J. Med. Chem.  1997,  40:  4169 
  • 10 Martin-Ruiz CM. Court JA. Molnar E. Lee M. Gotti C. Mamalaki A. Tsouloufis T. Tzartos S. Ballard C. Perry RH. Perry EK. J. Neurochem.  1999,  73:  1635 
  • 11 Addy NA. Nakijama A. Levin ED. Cogn. Brain Res.  2003,  16:  51 
  • 12 Wang H. Lee DHS. Davis CB. Shank RP. J. Neurochem.  2000,  75:  1155 
  • 13 Perry E. Martin-Ruiz C. Lee M. Griffiths M. Johnson M. Piggot M. Haroutunian V. Buxbaum JD. Nasland J. Davis K. Gotti C. Clementi F. Tzartos S. Cohen O. Soreq H. Jaros E. Perry R. Ballard C. McKeith I. Court J. Eur. J. Pharmacol.  2000,  393:  215 
  • 14 Selkoe DJ. Trends Cell. Biol.  1998,  8:  447 
  • 15 Pettit DL. Shao Z. Yakel JL. J. Neurosci.  2001,  21:  RC120 
  • 16 Dougherty JJ. Wu J. Nichols RA. J. Neurosci.  2003,  23:  6740 
  • 17 Sharples CGV. Wonnacott S. Tocris Reviews  2001,  19:  1 
  • 18 Dinley KT. Westerman M. Bui D. Bell K. Ashe KH. Sweatt JD. J. Neurosci.  2001,  21:  4125 
  • 19 Whiteaker P. Marks MJ. Grady SR. Lu Y. Picciotto MR. Changeux J. Collins AC. Eur. J. Pharmacol.  2000,  393:  123 
  • 20 Romanelli MN. Gualtieri F. Med. Res. Rev.  2003,  24:  393 
  • 21 Dwoskin LP. Crooks PA. J. Pharmacol. Exp. Ther.  2001,  298:  395 
  • 22 Manske RHF. Can. J. Res.  1938,  16:  B, 57 
  • 23 Wonnacott S. Albuquerque EX. Bertrand D. Methods Neurosci.  1993,  12:  263 
  • 24 Goodson JA. J. Chem. Soc.  1943,  139 
  • 25 Ulubelen A. Desai HK. Srivastava SK. Hart BP. Park J.-C. Joshi BS. Pelletier SW. Mericli AH. Mericli F. Ilarslan R. J. Nat. Prod.  1996,  59:  360 
  • 26 Jennings KR. Brown DG. Wright DP. Experientia  1986,  42:  611 
  • 27 Ward JM. Cockcroft VB. Lunt GG. Smillie FS. Wonnacott S. FEBS Lett.  1990,  270:  45 
  • 28 Lind RJ. Hardick DJ. Blagbrough IS. Potter BVL. Wolstenholme AJ. Davies ARL. Clough MS. Earley FGP. Reynolds SE. Wonnacott S. Insect Biochem.  2001,  31:  533 
  • 29 Panter KE. Manners GD. Stegelmeir BL. Lee S. Gardner DR. Ralphs MH. Pfister JA. James LF. Biochem. Syst. Ecol.  2002,  30:  113 
  • 30 Hardick DJ. Blagbrough IS. Cooper G. Potter BVL. Critchley T. Wonnacott S. J. Med. Chem.  1996,  39:  4860 
  • 31 Jacyno JM. Harwood JS. Lin N. Campbell JE. Sullivan JP. Holladay MW. J. Nat. Prod.  1996,  59:  707 
  • 32 Kukel CF. Jennings KR. Can. J. Physiol. Pharmacol.  1994,  72:  104 
  • 33 Manners GD. Panter KE. Pelletier SW. J. Nat. Prod.  1995,  58:  863 
  • 34 Manners GD. Panter KE. Pfister JA. Ralphs MH. James LF. J. Nat. Prod.  1998,  61:  1086 
  • 35 Gardner DR. Manners GD. Panter KE. Lee ST. Pfister JA. J. Nat. Prod.  2000,  63:  1127 
  • 36 Blagbrough IS. Coates PA. Hardick DJ. Lewis T. Rowan MG. Wonnacott S. Potter BV. Tetrahedron Lett.  1994,  35:  8705 
  • 37 Coates PA. Blagbrough IS. Hardick DJ. Rowan MG. Wonnacott S. Potter BV. Tetrahedron Lett.  1994,  35:  8701 
  • 38 Blagbrough IS. Hardick DJ. Wonnacott S. Potter BVL. Tetrahedron Lett.  1994,  35:  3367 
  • 39 Hardick DJ. Blagbrough IS. Wonnacott S. Potter BVL. Tetrahedron Lett.  1994,  35:  3371 
  • 40 Pelletier SW. Ross SA. Heterocycles  1990,  31:  671 
  • 41 Ross SA. Pelletier SW. Heterocycles  1991,  32:  1307 
  • 42 Davies ARL. Hardick DJ. Blagbrough IS. Potter BVL. Wolstenholme AJ. Wonnacott S. Neuropharmacology  1999,  38:  679 
  • 43 Hardick DJ. Blagbrough IS. Potter BVL. J. Am. Chem. Soc.  1996,  118:  5897 
  • 44 Navarro HA. Zhong D. Abraham P. Xu H. Carroll FI. J. Med. Chem.  2000,  43:  142 
  • 45 Bergmeier SC. Lapinsky DJ. Free RB. McKay DB. Bioorg. Med. Chem. Lett.  1999,  9:  2263 
  • 46 Byant DL. Free RB. Thomasy SM. Lapinsky DJ. Ismail KA. McKay SB. Bergmeier SC. McKay DB. Neurosci. Res.  2002,  42:  57 
  • 47 Ismail KA. Bergmeier SC. Eur. J. Med. Chem.  2002,  469 
  • 48 Doisy X. Blagbrough IS. Wonnacott S. Potter BVL. Pharm. Pharmacol. Commun.  1998,  4:  313 
  • 49 Simoni D. Rossi M. Rondanin R. Baruchello R. Grisolia G. Eleopra M. Giovannini R. Bozzoli A. Davalli S. Di Fabio R. Donati D. Tetrahedron Lett.  2005,  46:  759 
  • 50 Coates PA. Blagbrough IS. Rowan MG. Potter BVL. Pearson DPJ. Lewis T. Tetrahedron Lett.  1994,  35:  8709 
  • 51 Coates PA. Blagbrough IS. Rowan MG. Pearson DPJ. Lewis T. Potter BVL. J. Pharm. Pharmacol.  1996,  48:  210 
  • 52 Grangier G. Trigg WJ. Lewis T. Rowan MG. Potter BVL. Blagbrough IS. Tetrahedron Lett.  1998,  39:  889 
  • 53 Trigg WJ. Grangier G. Lewis T. Rowan MG. Potter BVL. Blagbrough IS. Tetrahedron Lett.  1998,  39:  893 
  • 54 Callis DJ. Thomas NF. Pearson DPJ. Potter BVL. J. Org. Chem.  1996,  61:  4634 
  • 55 Baillie LC. Bearder JR. Whiting DA. J. Chem. Soc., Chem. Commun.  1994,  2487 
  • 56 Baillie LC. Batsanov A. Bearder JR. Whiting DA. J. Chem. Soc., Perkin Trans. 1  1998,  3471 
  • 57 Baillie LC. Bearder JR. Sherringham JA. Whiting DA. J. Chem. Soc., Perkin Trans. 1  1997,  2687 
  • 58 Baillie LC. Bearder JR. Li W.-S. Sherringham JA. Whiting DA. J. Chem. Soc., Perkin Trans. 1  1998,  4047 
  • 59 Kraus GA. Dneprovskaia E. Tetrahedron Lett.  1998,  39:  2451 
  • 60 Kumar P. Dinesh CU. Pandey B. Tetrahedron Lett.  1994,  35:  9229 
  • 61 Barker D. Brimble MA. McLeod MD. Synthesis  2003,  656 
  • 62 Barker D. Brimble MA. McLeod MD. Savage GP. Wong DJ. J. Chem. Soc., Perkin Trans. 1  2002,  924 
  • 63 Barker D. McLeod MD. Brimble MA. Savage GP. Tetrahedron Lett.  2001,  42:  1785 
  • 64 Barker D. Brimble MA. McLeod MD. Savage GP. Tetrahedron  2004,  60:  5953 
  • 65 Barker D. McLeod MD. Brimble MA. Savage GP. Tetrahedron Lett.  2002,  43:  6019 
  • 66 Barker D. Brimble MA. McLeod MD. Savage GP. Org. Biomol. Chem.  2004,  2:  1659 
  • 67 Brocke C. Brimble MA. Lin DS.-H. McLeod MD. Synlett  2004,  2359 
  • 68 Davies ARL. Hardick DJ. Blagbrough IS. Potter BVL. Wolstenholme AJ. Wonnacott S. Biochem. Soc. Trans.  1997,  25:  5455 
  • 69 Kraus GA. Andersh B. Su Q. Shi J. Tetrahedron Lett.  1993,  34:  1741 
  • 70 Kraus GA. Shi J. J. Org. Chem.  1991,  56:  4147 
  • 71 Kraus GA. Shi J. J. Org. Chem.  1990,  55:  5423 
  • 72 Kraus GA. Kesavan S. Tetrahedron Lett.  2005,  46:  1111